Daniele Donati
Varese, 21100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Effects of Music Genres Reflecting Maternal Listening Preferences During Pregnancy on Distress Markers in Italian Preterm Infants.
Journal: Children (Basel, Switzerland)
Published: April 29, 2026
Stereoselective synthesis of 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as PIM kinase inhibitors inspired from marine alkaloids.
Journal: Chirality
Published: May 14, 2022
Identification of unprecedented ATP-competitive choline kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: April 27, 2021
Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
Journal: Journal of medicinal chemistry
Published: August 20, 2019
Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515.
Journal: ACS medicinal chemistry letters
Published: November 22, 2018
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
Journal: Journal of medicinal chemistry
Published: March 23, 2016
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
Journal: Molecular cancer therapeutics
Published: September 11, 2015
Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy.
Journal: Journal of medicinal chemistry
Published: July 30, 2015
Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: January 14, 2015
Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders.
Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders.
Journal: Bioorganic & medicinal chemistry
Published: January 12, 2015
Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.
Journal: Journal of medicinal chemistry
Published: December 05, 2014
Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effect.
Journal: ChemMedChem
Published: September 30, 2014
Last Updated: 09/26/2026